Aerobic glycolysis activation through canonical WNT/β-catenin pathway in ALS

被引:6
|
作者
Vallee, Alexandre [1 ]
机构
[1] Univ Poitiers, CHU Poitiers, UMR CNRS 7348, LMA, 2 Rue Mileterie, F-86021 Poitiers, France
来源
M S-MEDECINE SCIENCES | 2018年 / 34卷 / 04期
关键词
AMYOTROPHIC-LATERAL-SCLEROSIS; SPINAL-CORD; SIGNALING PATHWAY; PYRUVATE-KINASE; WNT; PATHOGENESIS; BRAIN; METABOLISM; ISOFORM; TARGETS;
D O I
10.1051/medsci/20183404013
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Energy is the major determinant of neuronal viability. We focus our synthesis on the hypothesis of the development of aerobic glycolysis by the stimulation of the canonical WNT/beta-catenin pathway in amyotrophic lateral sclerosis (ALS). The stimulation of the canonical WNT/beta-catenin pathway induces the activation of aerobic glycolysis, also called Warburg effect, via the stimulation of glycolytic enzymes such as Glut (glucose transporter), PKM2 (pyruvate kinase M2), PDK1 (pyruvate dehydrogenase kinase 1), LDH-A (lactate dehydrogenase A) and MCT-1 (monocarboxylate transporter 1). The aerobic glycolysis consists to a supply of a large part of glucose into lactate regardless of oxygen. Aerobic glycolysis is less efficient in terms of ATP production than oxidative phosphorylation due to the shunt of the TCA cycle. Dysregulation of cellular energy metabolism promotes cell death and participates to the progression of ALS. Controlling the expression of the canonical WNT/beta-catenin signaling pathway is an attractive strategy to regulate aerobic glycolysis initiation and the progression of ALS.
引用
收藏
页码:326 / 330
页数:5
相关论文
共 50 条
  • [31] The Wnt receptor FZD1 mediates chemoresistance in neuroblastoma through activation of the Wnt/β-catenin pathway
    M Flahaut
    R Meier
    A Coulon
    K A Nardou
    F K Niggli
    D Martinet
    J S Beckmann
    J-M Joseph
    A Mühlethaler-Mottet
    N Gross
    Oncogene, 2009, 28 : 2245 - 2256
  • [32] The phytoestrogen glabrene prevents osteoporosis in ovariectomized rats through upregulation of the canonical Wnt/β-catenin signaling pathway
    Liu, Jun
    Deng, Xinchang
    Liang, Xiao
    Li, Longying
    JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY, 2021, 35 (02)
  • [33] Wnt11 inhibits the canonical Wnt pathway through the activation of non-canonical signaling in human hepatocellular carcinoma cells
    Toyama, Takashi
    Lee, Han Chu
    Wands, Jack R.
    Kim, Miran
    HEPATOLOGY, 2006, 44 (04) : 593A - 593A
  • [34] Human Cytomegalovirus Infection Dysregulates the Canonical Wnt/β-catenin Signaling Pathway
    Angelova, Magdalena
    Zwezdaryk, Kevin
    Ferris, MaryBeth
    Shan, Bin
    Morris, Cindy A.
    Sullivan, Deborah E.
    PLOS PATHOGENS, 2012, 8 (10)
  • [35] Involvement of canonical Wnt/β-catenin signaling pathway in pancreatic ductal adenocarcinoma
    Sano, Makoto
    Driscoll, David
    Klimstra, David S.
    DeJesus-Monge, Wilfredo
    Lewis, Brian C.
    CANCER RESEARCH, 2012, 72
  • [36] Modulation of the canonical Wnt/-catenin signalling pathway in Helicobacter pylori infection
    Xia, G.
    Gnad, T.
    Lendeckel, U.
    Naumann, M.
    INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, 2007, 297 : 104 - 104
  • [37] Lithium regulates adult hippocampal progenitor development through canonical Wnt pathway activation
    Wexler, E. M.
    Geschwind, D. H.
    Palmer, T. D.
    MOLECULAR PSYCHIATRY, 2008, 13 (03) : 285 - 292
  • [38] Lithium regulates adult hippocampal progenitor development through canonical Wnt pathway activation
    E M Wexler
    D H Geschwind
    T D Palmer
    Molecular Psychiatry, 2008, 13 : 285 - 292
  • [39] Moracin M promotes hair regeneration through activation of the WNT/β-catenin pathway and angiogenesis
    Chang, Boyoon
    Hwang, Yuri
    Kim, In
    Park, Hyungmin
    Kim, Yonghwan
    Kim, Sungyeon
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2025, 317 (01)
  • [40] Curcumin: a therapeutic strategy in cancers by inhibiting the canonical WNT/β-catenin pathway
    Alexandre Vallée
    Yves Lecarpentier
    Jean-Noël Vallée
    Journal of Experimental & Clinical Cancer Research, 38